Polymorphism of A118G in μ-opioid receptor gene is associated with risk of esophageal squamous cell carcinoma in a Chinese population

International Journal of Clinical Oncology

Volumn 18, Issue 4, 2013, Pages 666-669

  Wang, Song ^a   Li, Yang ^a   Liu, Xiang Dong ^a   Zhao, Chun Xiong ^b   Yang, Kun Qing ^a  

^a HUBEI UNIVERSITY FOR NATIONALITIES   (China)

^b The Central Hospital of Enshi Prefecture   (China)

Author keywords

Opioid receptor; A118G polymorphism; Case control; Esophageal squamous cell carcinoma (ESCC)

Indexed keywords

MU OPIATE RECEPTOR;

ADULT; AGE; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CHINA; CHINESE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ETHNICITY; FAMILY HISTORY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MU OPIATE RECEPTOR GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHINA; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RECEPTORS, OPIOID, MU;

EID: 84882595605     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-012-0441-5     Document Type: Article

References (23)

1. Singleton PA et al (2006) Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation. Microvasc Res 72(1-2):3-11
2. Parkin DM et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74-108
3. Enzinger PC, Mayer RJ (2003) Esophageal cancer. N Engl J Med 349(23):2241-2252
4. Bovill JG (2010) Surgery for cancer: does anesthesia matter? Anesth Analg 110(6):1524-1526
5. Lennon FE, Moss J, Singleton PA (2012) The mu-opioid receptor in cancer progression: is there a direct effect? Anesthesiology 116(4):940-945
6. Afsharimani B, Cabot P, Parat MO (2011) Morphine and tumor growth and metastasis. Cancer Metastasis Rev 30(2):225-238
7. Leo S, Nuydens R, Meert TF (2009) Opioid-induced proliferation of vascular endothelial cells. J Pain Res 2:59-66
8. Gupta K et al (2002) Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res 62(15):4491-4498
9. Su JL et al (2007) The role of the VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer 96(4):541-545
10. Schultze A et al (2012) VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma. Clin Exp Metastasis. doi: 10.1007/s10585-012-9477-1
11. Shabalina SA et al (2009) Expansion of the human mu-opioid receptor gene architecture: novel functional variants. Hum Mol Genet 18(6):1037-1051
12. Zhang Y et al (2005) Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem 280(38):32618-32624
13. Bortsov AV et al (2012) Mu-opioid receptor gene A118G polymorphism predicts survival in patients with breast cancer. Anesthesiology 116(4):896-902
14. Chou WY et al (2006) Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiol Scand 50(7):787-792
15. Reyes-Gibby CC et al (2007) Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. Pain 130(1-2):25-30
16. Kamangar F et al (2009) Environmental causes of esophageal cancer. Gastroenterol Clin North Am 38(1):27-57 (vii)
17. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215
18. Kasai S, Ikeda K (2011) Pharmacogenomics of the human micro-opioid receptor. Pharmacogenomics 12(9):1305-1320
19. Tavare AN et al (2012) Cancer recurrence after surgery: direct and indirect effects of anesthetic agents. Int J Cancer 130(6):1237-1250
20. Gach K et al (2011) The role of morphine in regulation of cancer cell growth. Naunyn Schmiedebergs Arch Pharmacol 384(3):221-230
21. Biki B et al (2008) Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology 109(2):180-187
22. Exadaktylos AK et al (2006) Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 105(4):660-664
23. Ray R et al (2011) Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. Proc Natl Acad Sci USA 108(22):9268-9273